Phase II Study of LM-24C5

Clinical trial NCT07387081 · RECRUITING

Trial details

NCT number: NCT07387081
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Cancer

Start date: 2025-12-15
Primary completion: 2028-05-21
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.